Mucormycosis in systemic autoimmune diseases

Joint Bone Spine

Volumn 81, Issue 4, 2014, Pages 303-307

  Royer, Mathieu ^a   Puéchal, Xavier ^b,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSTITUT COCHIN   (France)

^c Institut Cochin   (France)

Author keywords

Immunosuppressive drugs; Mucormycosis; Opportunistic infections; Systemic autoimmune diseases

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; ADALIMUMAB; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUCONAZOLE; METHOTREXATE; POSACONAZOLE;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; CAVERNOUS SINUS THROMBOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FATALITY; GRANULOMATOSIS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KETOACIDOSIS; MUCORMYCOSIS; NECROTIZING ARTERITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; ABDOMINAL PAIN; CORTICOSTEROID THERAPY; COUGHING; EARLY DIAGNOSIS; FEVER; PURPURA; SYSTEMIC VASCULITIS; VISUAL ACUITY; VOMITING;

IMMUNOSUPPRESSIVE DRUGS; MUCORMYCOSIS; OPPORTUNISTIC INFECTIONS; SYSTEMIC AUTOIMMUNE DISEASES;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MUCORMYCOSIS; YOUNG ADULT;

EID: 84904118826     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2014.01.002     Document Type: Short Survey

References (36)

1. Spellberg B., Walsh T.J., Kontoyiannis D.P., et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009, 48:1743-1751.
2. Mantadakis E., Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect 2009, 15:15-20.
3. Spellberg B., Edwards J., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005, 18:556-569.
4. Lanternier F., Dannaoui E., Morizot G., et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis 2012, 54:S35-S43.
5. Petrikkos G., Skiada A., Lortholary O., et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012, 54:S23-S34.
6. Arce-Salinas C.A., Peres-Silva E. Mucormycosis complications in systemic lupus erythematosus. Lupus 2010, 33:115-124.
7. Shenoi S., Emery H.M. Successful treatment of invasive gastric mucormycosis in a child with systemic lupus erythematosus. Lupus 2010, 19:646-649.
8. Peel T., Daffy J., Thursky K., et al. Posaconazole as first line treatment for disseminated mucormycosis. Mycoses 2008, 51:542-545.
9. Yu J., Li R.Y. Primary renal mucormycosis due to Rhizopus oryzae. Med Mycol 2006, 44:461-466.
10. Fujimoto A., Nagao K., Tanaka K., et al. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus. Br J Dermatol 2005, 153:428-430.
11. Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth 2002, 49:880-882.
12. Sungkanuparph S., Sathapatayavongs B., Kunachak S., et al. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases. J Med Assoc Thai 2001, 84:593-601.
13. Liu M.F., Chen F.F., Hsiue T.R., et al. Disseminated mucormycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 2000, 19:311-314.
14. Hosseini M., Lee J. Gastrointestinal mucormycosis mimicking ischemic colitis in a patient with systemic lupus erythematosus. Am J Gastroenterol 1998, 93:1360-1362.
15. Dickinson M., Kalayanamit T., Yang C.A., et al. Cutaneous zygomycosis (mucormycosis) complicating endotracheal intubation: diagnosis and successful treatment. Chest 1998, 114:340-342.
16. Fingerote R.J., Seigel S., Atkinson M.H., et al. Disseminated mucormycosis associated with systemic lupus erythematosus. J Rheumatol 1990, 17:1692-1694.
17. Bloxham C.A., Carr S., Ryan D.W. Disseminated mucormycosis and systemic lupus erythematosus. Intensive Care Med 1990, 16:201-207.
18. Wong K.L., Tai Y.T., Loke S.L. Disseminated mucormycosis masquerading as cerebral lupus erythematosus. Am J Clin Pathol 1986, 86:546-549.
19. Mok C.C., Que T.L., Tsui E.Y., et al. Mucormycosis in systemic lupus erythematosus. Semin Arthritis Rheum 2003, 33:115-124.
20. Escobar A., Del Brutto O.H. Multiple brain abscesses from isolated cerebral mucormycosis. J Neurol Neurosurg Psychiatry 1990, 53:431-433.
21. Coffey M.J., Fantone J., Stiring M.C., et al. Pseudoaneurysm of pulmonary artery in mucormycosis. Am Rev Respir Dis 1992, 145:1487-1490.
22. Figueroa-Damian R., Torres-Gonzales F.E. Zygomyocosis in children. Report of two cases. Bol Med Hosp Infant Mex 1993, 50:813-818.
23. Del Real M.O., Zamora Q.J., Abud-Mendoza C., et al. Mucormicosis. Rev Invest Clin 1983, 35:237-240.
24. Kumar P., Begum C.Z., Thirumaran P., et al. Rhino cerebral mucormycosis in systemic lupus erythematosus. Indian J Dermatol 2013, 58:158.
25. Singh P., Taylor S.F., Murali R., et al. Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumour necrosis factor alpha inhibitor. Clin Experiment Ophthalmol 2007, 35:275-280.
26. Nogueira E.L., Ind P.W., Friedland J.S., et al. Mucormycosis may mimic disease relapse in Wegener's granulomatosis. J Rheumatol 2010, 37:1364-1365.
27. Royer M., Cervera P., Kahan A., et al. Mucormycosis cerebral arteritis mimicking a flare in ANCA-associated vasculitis. Lancet Infect Dis 2013, 13:182.
28. Berenguer J., Solera J., Moreno S., et al. Mucormycosis. The disease spectrum in 13patients. Med Clin (Barc) 1990, 94:766-772.
29. Richardson M. The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect 2009, 15:2-9.
30. Nosari A., Oreste P., Montillo M., et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000, 85:1068-1071.
31. Roden M.M., Zaoutis T.E., Buchanan W.L., et al. Epidemiology and outcome of zygomycosis: a review of 929reported cases. Clin Infect Dis 2005, 41:634-653.
32. Lass-Flörl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect 2009, 15:60-65.
33. Holle J.U., Gross W.L. Neurological involvement in Wegener's granulomatosis. Curr Opin Rheumatol 2011, 23:7-11.
34. Dannaoui E. Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Clin Microbiol Infect 2009, 15:66-70.
35. Skiada A., Lanternier F., Groll A.H., et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013, 98:492-504.
36. Petrikkos G.L. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Clin Microbiol Infect 2009, 15:87-92.